Graves病患者血清可溶性白介素2受体的探讨  

Serum sIL 2R in patients with Graves disease

作　　者：刘素筠[1] 刘知建[1] 张桂芬[1] 

机构地区：[1]山西医科大学第二临床医学院内分泌科

出　　处：《山西医科大学学报》1997年第3期174-175,共2页Journal of Shanxi Medical University

摘　　要：对２８例Ｇｒａｖｅｓ病的可溶性白介素２受体（ｓＩＬ２Ｒ）和各种甲状腺激素以及甲状腺自身抗体治疗前后比较，并进行逐步回归，结果表明：治疗后Ｇｒａｖｅｓ病患者除ＴＳＨ外，各种甲状腺激素及甲状腺自身抗体显著降低（Ｐ＜００１），并对ｓＩＬ２Ｒ的上升与下降呈显著相关。Serum soluble interleukin 2 receptor (sIL 2R) and thyroid hormones were determined,and thyroid self antibody were compared before and after therapy.The results showed that thyroid hormones,except TSH,and thyroid self antibody significantly decreased after therapy (P<0 01).

关 键 词：GRAVES病 血清 SIL-2R 

分 类 号：R581.1[医药卫生—内分泌]